VivoSeq
Other

Severe Mental Illness

0

Pipeline Programs↗

3

Active Trials↗

1

Companies Involved↗

Severe Mental Illness is an early-stage landscape with 0 programs across 1 company. The most active players are Medizinische Hochschule Brandenburg Theodor Fontane.

Intelligence

Pipeline Metrics

Competitive Density

14/100

Pipeline Velocity

6/100

Mech. Concentration

N/A

Completion Rate

100/100

Attrition Rate

0/100

Competition

Competitive Landscape

Bubble size = clinical trials

Approved
Phase 3
Phase 2
Phase 1
Preclinical

Key Players

Top Companies Companies ranked by the number of pipeline programs they run for this disease.

M

Medizinische Hochschule Brandenburg Theodor Fontane

0 programs

Preclinical

Pipeline

Programs by Phase

No pipeline programs currently tracked for this disease.

Analysis

Trial Status

4

clinical trials

Active, not recruiting2 · 50%
Completed1 · 25%
Enrolling by invitation1 · 25%

Clinical Trials

Trial Activity

Intranasal Oxytocin as Enhancer of Psychotherapy Outcomes in Severe Mental Illness
Active, not recruiting·SShalvata Mental Health Center·Phase 2·NCT03566069·120 enrolled
Multicomponent Risk Factor Intervention for People With a Severe Mental Illness: a Feasibility Study
Completed·TThe University of New South Wales·Phase 2·NCT00350311·43 enrolled
Improving Outcome Through Improving Cognition in Severe Mental Illness: Cognitive Remediation Training Combined With Transcranial Direct Current Stimulation, a Randomized, Sham-controlled, Multi-center Trial
Active, not recruiting·University of Groningen·Preclinical·NCT06378463·126 enrolled
Use of AI Chatbots for Mental Health - an Online Survey of Patients With Severe Mental Illness
Enrolling by invitation·MMedizinische Hochschule Brandenburg Theodor Fontane·N/A·NCT07658547·150 enrolled

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)